Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Corcept Therapeutics
Pfizer
Pathos AI, Inc.
Stemline Therapeutics, Inc.
Turning Point Therapeutics, Inc.
Alterome Therapeutics, Inc.
Boston Scientific Corporation
Eli Lilly and Company
K36 Therapeutics, Inc.
Ensem Therapeutics
Pfizer
Eli Lilly and Company
Revolution Medicines, Inc.
DL Analytics
Intuitive Surgical
Genelux Corporation
Plus Therapeutics
Marengo Therapeutics, Inc.
Cogent Biosciences, Inc.
Novartis
Endocyte
UroGen Pharma Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
OncoSil Medical Limited
Concure Oncology-Breast Microseed Inc.